Lifestyle

Wuling Capsule for Insomnia in Adults: How Safe and Effective Is It?

In a retrospective, systematic review, researchers assessed the effectiveness and safety profile of Wuling for the treatment of insomnia.

Anxiety and Depression: Understanding the Risk for Preeclampsia

Rates of anxiety and depression have increased during the pandemic and are linked to preeclampsia risk, making screening for mental health conditions at prenatal visits essential.

Integrated Cognitive and Balance Intervention Improves Depression Symptoms

The ENGAGE-2 Mechanistic Pilot trial was a randomized clinical trial conducted at the University of Illinois at Chicago and Stanford University between 2019 and 2020.

Warning Letters Sent to Companies Marketing Delta-8 THC Products as Treatments

The FDA has expressed serious concerns related to the potential health effects for patients who have consumed delta-8 THC products.

Resilience Mediates Anxiety, Depression in Youth Who Experience Bullying

This study was a cross-sectional analysis of data from the Youth Aware of Mental Health promotion program which took place in Texas.

Social Determinants Affect Treatment Response in Those With Major Depression

The researchers evaluated socioeconomic data from the 2011 Combining Medications to Enhance Depression Outcomes (CO-MED) study to ascertain whether social determinants affect treatment response in those with major depression.

Neonatal Exposure to Antipsychotics Does Not Substantially Increase Risk for Neurodevelopmental Disorders

Investigators with Brigham and Women’s Hospital sourced data for this study from the Medicaid Analytic eXtract (MAX) and IBM Health MarketScan Research Database.

Firearm Suicide Decedents More Likely to Disclose Their Plans 1-Month Prior to Death

Decedents in this study were evaluated for previous suicide attempt, their history of mental health treatment and substance use, and treatment at the time of their death.

A Perfect Storm: Rise in Eating Disorders Among Teens During COVID-19

Eating disorders among adolescents have doubled since the start of the pandemic and patients are presenting with more severe symptoms.

Neuropeptide Levels Could Serve as Bipolar Disorder Biomarker

Researchers examined the effect of neuropeptides orexin-A, ghrelin, and neuropeptide Y on hypersomnia and hyperphagia. Both symptoms are more common in people with bipolar disorder.

Exercise Linked to Cardiovascular Benefit in Patients With Anxiety and Depression

Researchers examined the role of exercise in decreasing cardiovascular risk in patients with anxiety and depression.

Employment and Housing Status Contributes to Efficacy of Treatment for Depression

Publication databases were searched through October 2021 for randomized clinical trials of treatments for unipolar depression. Only studies that reported information about socioeconomic factors were included.

Antidepressants Have Modest Effect on Major Depressive Disorder Among Children

Investigators searched publication databases through January 2021 for placebo-controlled studies of treatment for MDD among pediatric patients.

Eating Disorder Screening and Treatment Updates From the USPSTF

USPSTF determines that more research is needed to recommend for or against screening in people without symptoms and provides updates on effective screening tools and pharmacotherapies.

Management Strategies for Pediatric Psychodermatologic Disorders

Current management techniques for some of the most common skin issues in children with psychiatric disorders are reviewed.

How Did the First Wave of COVID-19 Affect Behavioral Health and QOL?

Tulane University researchers asked respondents in an online survey to report the impact of their COVID-19 experiences and COVID-19 disruption, as well as any mental health, physical health, or alcohol problems they experienced before the COVID-19 pandemic.

Psychosis Risk Influenced by Early-Life Infection, Inflammation, and Metabolic Alterations

Three-quarters of all psychiatric disorders occur by early adulthood (mid-20s). This fact suggests that bio-psychosocial factors occurring from the fetal period through early adulthood could play a crucial role in risk. This nonsystematic review sought to synthesize key epidemiological evidence of relevant risk factors.

Using Apps to Improve Depression Care: 2 Models

Two experts speak about how apps address different needs and use different technologies, but taken together, they shed light on the manifold ways that apps can be used for depression management in clinical practice.

Depression Plus Sleep Disorder May Triple Heart Disease Risk

Depressive symptoms and sleep disorders, including insomnia, hypersomnia, and disrupted breathing, are considered heart disease risk factors. Other studies have linked sleep disorders and depression. This study analyzes heart disease risk in people with both sleep disorders and depression.

Osteoporosis Drug Linked to Depression and Anxiety

Studies show a link between depression and osteoporosis. Researchers investigated whether osteoporosis drugs contributed to depression and anxiety.